Literature DB >> 8253918

The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. II. Multiple discriminant analysis for risk prediction.

A Delvigne1, M Dubois, B Battheu, S Bassil, C Meuleman, P De Sutter, C Rodesch, P Janssens, P Remacle, S Gordts.   

Abstract

The considerable overlap of distributions of values for different parameters between control and ovarian hyperstimulation syndrome (OHSS) populations makes any single variable inefficient for risk prediction. Combinations of variables were studied in a discriminant function in order to increase predictivity and decrease the false negative rate. Such analyses were performed on two groups of in-vitro fertilization (IVF) patients: all OHSS cases (n = 128) (group A) and only severe OHSS cases (n = 92) (group B). Progressive introduction and automated stepwise selection of variables were applied to both groups. The best prediction (78.5%) was obtained in group A under post-oocyte retrieval conditions using log oestradiol, slope of log oestradiol increment, human menopausal gonadotrophin (HMG) dosage, number of oocytes retrieved and ratio of luteinizing hormone/follicle stimulating hormone (LH/FSH), in the formula. The corresponding false negative rate was 18.1%. However, effective prevention of OHSS implies the ability to withhold human chorionic gonadotrophin injection. Therefore a formula for pre-oocyte retrieval conditions was established yielding a prediction rate of 76.1% with a false negative rate of 18.1%. To be validated, such formulae have to be applied to another population of IVF cases used as a 'testing-set'.

Entities:  

Mesh:

Year:  1993        PMID: 8253918     DOI: 10.1093/oxfordjournals.humrep.a138261

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

1.  Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles.

Authors:  Pelin Ocal; Sezai Sahmay; Meral Cetin; Tulay Irez; Onur Guralp; Ismail Cepni
Journal:  J Assist Reprod Genet       Date:  2011-09-01       Impact factor: 3.412

2.  Ovarian hyperstimulation syndrome after assisted reproductive technologies: trends, predictors, and pregnancy outcomes.

Authors:  David A Schirmer; Aniket D Kulkarni; Yujia Zhang; Jennifer F Kawwass; Sheree L Boulet; Dmitry M Kissin
Journal:  Fertil Steril       Date:  2020-07-14       Impact factor: 7.329

3.  Predictive Factors for Recovery Time in Conceived Women Suffering From Moderate to Severe Ovarian Hyperstimulation Syndrome.

Authors:  Kai Huang; Ying Shi; Gezi Chen; Hao Shi; Jun Zhai
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-15       Impact factor: 6.055

4.  Mild/minimal stimulation protocol for ovarian stimulation of patients at high risk of developing ovarian hyperstimulation syndrome.

Authors:  L Rinaldi; F Lisi; H Selman
Journal:  J Endocrinol Invest       Date:  2014-01-08       Impact factor: 4.256

5.  Estradiol level on day 9 as a predictor of risk for ovarian hyperresponse during controlled ovarian hyperstimulation.

Authors:  Hsin-Yi Ho; Robert Kuo-Kuang Lee; Ming-Huei Lin; Yuh-Ming Hwu
Journal:  J Assist Reprod Genet       Date:  2003-06       Impact factor: 3.412

6.  Prediction of ovarian hyperstimulation syndrome in coasted patients in an IVF/ICSI program.

Authors:  Fatimah Y Aljawoan; Linda P Hunt; Uma D Gordon
Journal:  J Hum Reprod Sci       Date:  2012-01

7.  The perspective of women with an increased risk of OHSS regarding the safety and burden of IVF: a discrete choice experiment.

Authors:  S C Braam; J P de Bruin; B W J Mol; M van Wely
Journal:  Hum Reprod Open       Date:  2020-02-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.